Daihan Scientific Co Ltd

Daihan Scientific Co Ltd maintains a strong liquidity position with a current ratio of 3.68, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's liquidity_fpt of 4924425230 KRW in cash and equivalents further supports its ability to meet immediate financial obligations without relying on external financing. The company's profitability is reflected in its return on equity (ROE) of 7.3% and return on assets (ROA) of 4.54%. These metrics are in line with the industry_config preferred metrics for Medical Equipment, Supplies & Distribution, which emphasize asset efficiency and equity returns. The operating margin of 6.8% (calculated from operating income of 5530676720 KRW on revenue of 81117767870 KRW) suggests the company is effectively managing its operating costs relative to its revenue. Daihan Scientific Co Ltd's revenue is primarily concentrated in its domestic and overseas markets, with no disclosed segment breakdown. The company's geographic exposure is not specified in the input data, but its business model suggests a diversified approach to market access. The lack of segment-specific data limits the ability to assess revenue concentration risk in detail. The company's growth trajectory is supported by a positive free cash flow of 5574240790 KRW and a capital expenditure of -316508350 KRW, indicating that the company is generating more cash than it is investing in capital assets. The outlook for the current fiscal year suggests continued revenue growth, with no immediate dilution or liquidity risks identified in the risk assessment. The risk assessment for Daihan Scientific Co Ltd indicates a low liquidity risk and a low dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is supported by a low debt-to-equity ratio of 0.01. The absence of dilution potential and the company's strong liquidity position suggest a stable financial outlook. Recent events and filings for Daihan Scientific Co Ltd do not indicate any material changes in the company's financial or operational status. The company's latest financial snapshot shows consistent performance in terms of revenue, gross profit, and net income, with no significant deviations from historical trends. The lack of recent events or transcripts does not suggest any immediate operational or financial risks.